Extended Nirmatrelvir/Ritonavir Beneficial for Some With Long COVID
Meaningful reduction in symptoms seen for some taking an extended course outside of the context of an acute infection
Gender-Affirming Medication Use Rare in U.S. Transgender Adolescents From 2018 to 2022
Findings seen among privately insured adolescents who identify as transgender and gender-diverse
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation
Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates
DoxyPEP Tied to Decreases in Sexually Transmitted Infections
Substantial declines seen in chlamydia and syphilis incidence after initiation
Incident Gabapentin Use Not Linked to Increase in Falls Versus Duloxetine
Findings seen in older adults with diabetic neuropathy, postherpetic neuralgia, or fibromyalgia
Immunocompromised Have Heterogeneous Antibody Response to RSV Vaccines
Median four-week preF IgG fold rise was 4.21; 61 percent of participants achieved seroconversion
Gestational Exposure to NSAIDs Tied to Childhood Chronic Kidney Disease
However, no association seen between NSAID use and fetal nephrotoxicity in sibling comparisons
Early Anti-TNFα Therapy Cuts Perianal Fistula Complications in Pediatric Crohn Disease
Odds of complications significantly reduced with early anti-TNFα therapy, especially in those with perianal lesions
FDA Approves Subcutaneous Opdivo Qvantig for Most Solid Tumor Indications
Approval based on noninferior pharmacokinetic exposures, similar effectiveness and safety to intravenous Opdivo
